B6.Cg-Tg(Met,-lacZ)#Buck/Orl

Status

Available to order

EMMA IDEM:05742
International strain nameB6.Cg-Tg(Met,-lacZ)#Buck/Orl
Alternative nameB6.P34TKZI
Strain typeTransgenic Strains
Allele/Transgene symbolTg(Pax3CSS)5-TK-nLacZ
Gene/Transgene symbolTg(Pax3CSS)5-TK-nLacZ

Information from provider

ProviderFrederic RELAIX
Provider affiliationGroupe Myologie, UMR-S 787 - INSERM - UPMC-Paris VI - Institut de Myologie
Additional ownerMargaret Buckingham, Molecular Genetics of Development (URA CNRS 2578), Institut Pasteur, Paris, France
Genetic informationOligonucleotides containing the Pax3 consensus binding site defined by Epstein et al. (1996) were multimerized. The sequence of the oligonucleotides is as follows: CSSPax3-A, 5-CCTCGTCACGCTTCGAATGT-3; and CSSPax3-B, 5-GGGACATTCGAAGCGTGACGA-3. The oligonucleotides were annealed and polymerized. Concatenamers containing five binding sites were gel-purified, and cloned into a TK-nLacZpA vector, which contains the nlacZ reporter gene under the control of the thymidine kinase (TK) promoter (Hadchouel et al. 2003), into an SfiI site located 5 to the TK minimal promoter. A 7.4-kb plasmid fragment for injection was isolated using XhoI and NotI as previously described (Kelly et al. 1995). Transgenic mice were generated as previously described (Hadchouel et al. 2003).
Phenotypic informationNormal, lacZ reporter for Pax3 gene
Breeding historyThe line has been backcrossed to C57BL/6 background for at least 10 generations.
References
  • Divergent functions of murine Pax3 and Pax7 in limb muscle development.;Relaix Frédéric, Rocancourt Didier, Mansouri Ahmed, Buckingham Margaret, ;2004;Genes & development;18;1088-105; 15132998
  • The transcriptional activator PAX3-FKHR rescues the defects of Pax3 mutant mice but induces a myogenic gain-of-function phenotype with ligand-independent activation of Met signaling in vivo.;Relaix Frédéric, Polimeni Mariarosa, Rocancourt Didier, Ponzetto Carola, Schäfer Beat W, Buckingham Margaret, ;2003;Genes & development;17;2950-65; 14665670
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredyes
Immunocompromisedno

Information from EMMA

Archiving centreInstitut de Transgenose, INTRAGENE, Orléans, France
Animals used for archivingheterozygous C57BL/6J, wild-type C57BL/6J
Stage of embryos2-cell

Literature references

  • Divergent functions of murine Pax3 and Pax7 in limb muscle development.;Relaix Frédéric, Rocancourt Didier, Mansouri Ahmed, Buckingham Margaret, ;2004;Genes & development;18;1088-105; 15132998
  • The transcriptional activator PAX3-FKHR rescues the defects of Pax3 mutant mice but induces a myogenic gain-of-function phenotype with ligand-independent activation of Met signaling in vivo.;Relaix Frédéric, Polimeni Mariarosa, Rocancourt Didier, Ponzetto Carola, Schäfer Beat W, Buckingham Margaret, ;2003;Genes & development;17;2950-65; 14665670

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).